Benefit and cost of repeating a severe acute respiratory coronavirus virus 2 (SARS-CoV-2) polymerase chain reaction (PCR) test after the second day of hospitalization in five hospitals during various community prevalences and vaccination rates
Open Access
- 16 June 2022
- journal article
- research article
- Published by Cambridge University Press (CUP) in Infection Control & Hospital Epidemiology
- Vol. 44 (1) , 106-109
Abstract
Universal SARS-CoV-2 PCR was performed upon admission and again after two inpatient days. As community-wide prevalence, admission, and vaccination rates varied, number-needed-to-benefit (NNB) and cost-per-additional-detection (Cd) fluctuated between 16-769 and 29,400 respectively, and negatively associated with new hospital admissions. No other community indicator associated with NNB and Cd.Keywords
This publication has 7 references indexed in Scilit:
- A cluster-control approach to a coronavirus disease 2019 (COVID-19) outbreak on a stroke ward with infection control considerations for dementia and vascular unitsInfection Control & Hospital Epidemiology, 2021
- Incidence and outcomes of healthcare-associated COVID-19 infections: significance of delayed diagnosis and correlation with staff absenceJournal of Hospital Infection, 2020
- High mortality among hospital-acquired COVID-19 infection in patients with cancer: A multicentre observational cohort studyEuropean Journal of Cancer, 2020
- Incidence of Nosocomial COVID-19 in Patients Hospitalized at a Large US Academic Medical CenterJAMA Network Open, 2020
- Temporal, Spatial, and Epidemiologic Relationships of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Gene Cycle Thresholds: A Pragmatic Ambi-directional ObservationClinical Infectious Diseases, 2020
- Variation in False-Negative Rate of Reverse Transcriptase Polymerase Chain Reaction–Based SARS-CoV-2 Tests by Time Since ExposureAnnals of Internal Medicine, 2020
- Late Diagnosis of COVID-19 in Patients Admitted to the HospitalJournal of General Internal Medicine, 2020